Therapeutic Medicines
-
Upload
khangsiean89 -
Category
Documents
-
view
5 -
download
0
description
Transcript of Therapeutic Medicines
Therapeutic Drug Monitoring and penicillin allergy
(Duty of care with toxic drugs)Dr Kieran Hand
Consultant Pharmacist, Anti-infectivesSUHT, November 2007
Why monitor drug levels?
• Optimise dose regimen for individual patient• Explain lack of efficacy• Prevent / confirm toxicity• Evaluate impact of drug interactions• Evaluate impact of low albumin• Evaluate impact of changes in organ function or
fluid status• Check patient compliance
Drugs routinely monitored
• Anti-epileptics– Phenytoin,
Carbamazepine, (Valproate)
• Antibiotics– Gentamicin,
Tobramycin– Vancomycin,
Teicoplanin
• Anti-psychotics– Lithium
• Cardiac glycosides– Digoxin
• Bronchodilators– Aminophylline– Theophylline
• Specialty drugs
eQuest screen - Lithium
eQuest screen - search
eQuest screen - antibiotics
Narrow therapeutic index
When to sample – steady state
The effect of loading dose – immediate efficacy
Blood sampling and the distribution phase
Anti-epileptics
PhenytoinHalf-life 22 hours but caution: saturable metabolism
Time to steady state sampling Varies considerably between patients (1-5 weeks)
Loading dose 18mg/kg slow iv infusion for status epilepticus over 30-60mins (ECG recommended)
Maintenance dose 100mg 6-8 hourly iv (convert to od if stable)200-500mg once daily po
When to take blood Pre-dose
How often to repeat Sample within 2-3 days of initiation then again 3-5 days later. If no change, monitor weekly.
Sampling method Li-heparin/SST
Signs of toxicity Far-lateral nystagmus, diplopia, ataxia, confusion, slurred speech, hyperglycaemia, respiratory/circulatory depression (2-5g lethal)
Target range 10-20mg/L (bound + free drug); Note: high protein binding
Practical issues 100mg iv = 100mg tablet = 90mg liquid
Phenytoin accumulation
Phenytoin – key points
• Saturable metabolism so increase dose carefully• Long half-life (1 day) so pointless to sample blood
before one week if initiating oral therapy• Serum levels must be adjusted for abnormal albumin
concentration – call a pharmacist (low albumin leads to plasma phenytoin level appearing low but tissue levels normal)
• Susceptible to protein binding displacement (plasma level appears low but tissue levels normal)
• Susceptible to liver enzyme inhibition and induction
CarbamazapineHalf-life 30hr then 15hr due to autoinduction
Time to steady state sampling 5-7 days after dose change
Loading dose Slow titration: 100-200mg bd oral > increasing by 100-200mg each week
Maintenance dose 200-800mg bd
When to take blood Pre-dose
How often to repeat After dose changes (5-7 days)
Sampling method Li-heparin/SST
Signs of toxicity Vomiting, CNS disturbances, tachycardia, haemodynamic instability, respiratory depression, coma
Target range 4-12mg/L
Carbamazepine – key points
• Autoinduces it’s own metabolism (one month)
• Wider therapeutic index than phenytoin• Susceptible to liver enzyme induction or
inhibition• Induces increased metabolism of other
drugs
Antibiotics
Gentamicin extended interval dosingC
once
ntra
tion
Time
Reduced elimination
Con
cent
ratio
n
Time
MEC
MTC
Reduced elimination
Con
cent
ratio
n
Time
MEC
MTC
GentamicinHalf-life 2-3 hours
Time to steady state sampling
6-14 hours post 1st dose sampling window for 5mg/kg regimenBefore and after 3rd dose for 8-hourly dosing
Loading dose Not applicable
Maintenance dose 5mg/kg every 24, 36 or 72 hours or1mg/kg every 8-12 hours
When to take blood 6-14 hours post-dose for 5mg/kg dosing regimenPre-dose for trough1 hour after start of infusion for peak (distribution phase)
How often to repeat Twice weekly if renal function and fluid status stable
Sampling method Plain tube (clotted blood - red top)
Signs of toxicity Nephrotoxicity and renal failure, ototoxicity (vestibular damage or hearing loss)
Target range High-dose regimen – see nomogram8-hourly regimen – peak 5-10mg/L, trough <1.0mg/L for Gram –ve sepsis
Gentamicin – key points
• Gentamicin causes permanent renal failure if levels are kept above 1mg/L for a prolonged period of time
• High-dose regimen (5mg/kg) equally effective as traditional dosing
• High-dose regimen no more toxic than traditional dosing
• See SUHTranet for exclusion criteria
VancomycinHalf-life 6-7 hours
Time to steady state sampling Pre-dose at 3rd or 4th dose
Loading dose 1-1.5 grams
Maintenance dose 1.5 grams bd (see intermittent dosing guideline)
When to take blood Pre-dose
How often to repeat Every 3 days if renal function stable
Sampling method Plain tube (clotted blood - red top)
Signs of toxicity Rapid infusion causes ‘Red Man Syndrome’Nephrotoxicity and renal failure; Ototoxicity with hearling loss, vertigo, dizziness, tinnitus
Target range 10-15mg/L (once daily or twice daily dosing)20-25mg/L continuous infusion
Vancomycin – key points
• Activity related to time levels are above MIC for target pathogen
• Vancomycin is rarely nephrotoxic if monitored carefully
• Nephrotoxicity is usually associated with concurrent prescribing of other nephrotoxic drugs
• ICU uses continuous infusion vancomycin
TeicoplaninHalf-life ONE WEEK
Time to steady state ONE MONTH
Loading dose 400mg 12-hourly for 3 doses is ESSENTIAL
Maintenance dose 400-600mg daily (at least 6mg/kg)
When to take blood Pre-dose
How often to repeat Monthly
Sampling method Plain tube (clotted blood - red top)
Signs of toxicity Renal failure, hearing loss, vestibular disorder, tinnitus
Target range Trough >10mg/L (>20mg/L for IE)Peak 20-50mg/L
Teicoplanin – key points
• Inferior efficacy to vancomycin• Frequently underdosed – associated with treatment
failure• Levels sent off to Bristol - delay• Advantage of once-daily dosing• Reduce dose on 4th day if renal impairment• Less nephrotoxic than vancomycin• Expensive
Cardiac glycosides
DigoxinHalf-life 30-40 hours
Time to steady state sampling >1 week
Loading dose IV 10 microgram/kg in 100mL saline over 2hroral 15 microgram/kg (750-1,500 micrograms in divided doses)
Maintenance dose 62.5micrograms – 250micrograms once daily
When to take blood Pre-dose preferably (at least 6 hours after oral dose to allow distribution)
How often to repeat 1 week after initiation or dose change
Sampling method Li-heparin/SST
Signs of toxicity Anorexia, nausea, vomiting, various arrhythmias, atrial tachycardia, 10-15mg fatal in adults,
Target range 1-2 microgram/L
Practical issues 125mcg tablet 100mcg liquid (2mL) 80mcg iv
Digoxin - key points
• Low potassium potentiates risk of arrhythmias• Maintenance dose usually guesstimated from
weight and renal function• Pharmacist can provide more accurate estimate• Clinically significant interaction with amiodarone• Digibind® reduces mortality in overdose but
phenytoin is a cheaper alternative in mild cases
Antipsychotics
LithiumHalf-life 24 hours
Time to steady state sampling 4-5 days after starting or change in therapy or sodium/fluid intake
Loading dose 400mg-1.2g daily
Maintenance dose 400mg – 1,200mg od po
When to take blood pre-dose
How often to repeat Weekly until dose stable then at least 3-monthly
Sampling method Plain tube
Signs of toxicity Hyperreflexia & hyperextension of limbs, convulsions, psychoses, syncope, renal failure, circulatory failure, coma, death
Target range 0.4 – 1.0 mmol/L
Practical issues Slow release brands not interchangeable
Lithium – key points
• Renal excretion– 100% filtered but 80% reabsorbed– Li+ reabsorption linked to Na+ reabsorption– Influenced by dehydration, sodium depletion,
hypotension– Diuretics (e.g. thiazides) can increase Lithium levels
dramatically• NSAIDs and ACEi’s can increase Li+ levels
toxicity
Bronchodilators
Theophylline /Aminophylline ivHalf-life 8 hours
Time to steady state sampling 2 hours post load, then 12 hours into infusionOral: 5 days after starting
Loading dose 5mg/kg iv if treatment naïve in 100mL over 20 mins
Maintenance dose Infusion 0.5mg/kg/hour (500mg in 500mL)Oral: 200-500mg 12-hourly (slow release)
When to take blood 24 hours into infusionOral – pre-dose (at least 4-6 hours post-dose)
How often to repeat As required
Sampling method Li-heparin/SST
Signs of toxicity Nausea, vomiting and haematemesis, agitation, restlessness, dilated pupils and convulsions, hypotension and life-threatening cardiac arrhythmias
Target range 10-20mg/L
Practical issues Slow release brands not interchangeableTheophylline 790 mg = Aminophylline 1,000mg
Theophylline / aminophylline key points
• Theophylline concentration is increased in– Heart failure– Cirrhosis– Elderly– Liver enzyme inhibitors
• Theophylline concentration is decreased by – Smoking– Social drinking– Liver enzyme inducers
Specialty drugs for monitoring – seek expert advice
• Immunosuppressants– Ciclosporin / Tacrolimus / Sirolimus– Methotrexate
• Anti-epileptics– Valproate– Phenobarbitol– Ethosuximide
• Tricyclic antidepressants– Amitriptyline, nortriptyline, imipramine etc
Important concepts• You prescribe a toxic drug – you monitor it• Seek advice from the ward pharmacist or Medicines Info• Loading dose for drugs with long half-life• Distribution phase (when to sample blood after dose given)• Documenting sampling times• Steady state (when to check levels after start of therapy or
change to therapy)• Actions: reducing dose or extending dosing interval• Slow-release brands are not easily interchangeable• Many TDM drugs are susceptible to serious drug interactions
– caution if starting/stopping other drugs and check with pharmacist or BNF
Penicillin allergy
• Megan, 19-years-old, student• PC ‘Serious infection’• Allergies ‘Penicillin – itchy rash and lips swollen’
• Rate the following antibiotics as:– Safe– Caution – perform risk assessment– Danger
Penicillin allergy
• Clindamycin• Amoxicillin• Moxifloxacin• Daptomycin• Doxycycline• Tazocin• Azithromycin• Gentamicin
• Metronidazole• Ceftriaxone• Vancomycin• Flucloxacillin• Meropenem• Cefuroxime• Augmentin• Rifampicin
Penicillin allergy
• Clindamycin• Amoxicillin• Moxifloxacin• Daptomycin• Doxycycline• Tazocin• Azithromycin• Gentamicin
• Metronidazole• Ceftriaxone• Vancomycin• Flucloxacillin• Meropenem• Cefuroxime• Augmentin• Rifampicin
Facts about penicillin allergy• 10-20% of patients
reporting a penicillin allergy are truly allergic (Salkind 2001 JAMA)
• Frequency of all ADRs to penicillin in general population is 0.7-10%
• Anaphylaxis occurs in between 1:6,500 and 1:25,000 penicillin courses
• History of atopy is not predictive of penicillin anaphylaxis but may severity
• Patients on beta-blockers may be at increased risk of death if anaphylaxis occurs
• Understanding the classification of penicillin hypersensitivity reactions helps with risk assessment
Gell and Coombs Classification
Time of onset after exposure
Mediator Clinical signs Skin testing useful
Comments
Type I (immediate)
< 1 hour after exposure
Penicillin-specific IgE antibodies
Anaphylaxis and/or laryngeal oedema, wheezing / bronchospasm, angioedema, urticaria/pruritis, diffuse erythema
Yes IV > oralFatal in 1:50,000-100,000 treatment coursesSome IgE reactions occur from 1-72 hours post exposure
Late reactions > 72 hours after exposure
Type II >72 hours IgG, complement
red blood cells, platelets
No clearance by lymphoreticular system
Type III >72 hours IgG, IgM immune complexes
Serum sickness, tissue injury
No Tissue lodging of immune complexes, drug fever
Type IV >72 hours Contact dermatitis No
Other (idiopathic)
Usually >72 hours
Unknown Maculopapular or morbilliform rashes
No 1-4% of all patients receiving penicillin 3.5% on rechallenge
Taking a History of Penicillin Allergy: What to Ask• What was the patient’s age at the time of the reaction? Type I reactions most common in 20-50 year olds
• Does the patient recall the reaction?If not, who informed them of it?
How reliable is the history?
• How long after beginning penicillin did the reaction begin?
If onset >3days after exposure then unlikely to be Type I reaction.
• What were the characteristics of the reaction?
If a detailed history of a patient’s reaction to penicillin indicates that the rash was strictly maculopapular, with no signs of a type I reaction, then it appears to be safe to readminister an antibiotic that contains penicillin.
• What was the route of administration? Type I reactions much more likely with parenteral administration
• Why was the patient taking penicillin?
Drug-independent rashes are common in patients with viral infections and infections with numerous bacteria can also be associated with a rash.
• What other medications was the patient taking? Why and when were they prescribed?
Did the reaction coincide with administration of other medications known to cause allergy?
• What happened when the penicillin was discontinued?
A positive dechallenge increases the likelihood of a true penicillin reaction
• Has the patient taken antibiotics similar to penicillin (for example, amoxicillin, ampicillin, cephalosporins) before or after the reaction? If yes, what was the result?
Cross-reactivity to cephalosporins and carbapenems is up to 10% for patients with Type I reaction to penicillins (avoid)
Questions?